MannKind (MNKD) News Today $3.54 -0.06 (-1.67%) Closing price 07/7/2025 04:00 PM EasternExtended Trading$3.55 +0.01 (+0.28%) As of 07/7/2025 07:53 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Headlines Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrendsBuy This Stock MNKD Latest News All Sources Trusted Sources MarketBeat Benzinga Bloomberg GlobeNewswire GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha TalkMarkets The Street TipRanks The Wall Street Journal Wall Street Zen Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent July 2025 June 2025 May 2025 April 2025 March 2025 February 2025 January 2025 December 2024 November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 September 2022 August 2022 Time Period MannKind (NASDAQ:MNKD) Hits New 52-Week Low - Here's WhyJuly 7 at 10:18 AM | marketbeat.comMannKind (NASDAQ:MNKD) Hits New 1-Year Low - What's Next?July 1, 2025 | marketbeat.comMannKind (NASDAQ:MNKD) Rating Lowered to Hold at Wall Street ZenJune 28, 2025 | americanbankingnews.comMannKind (NASDAQ:MNKD) Rating Lowered to "Hold" at Wall Street ZenJune 27, 2025 | marketbeat.comHealth Rounds: Inhaled insulin as good as injection for children at mealtimeJune 25, 2025 | reuters.comMannKind (NASDAQ:MNKD) Stock Price Down 5.6% - What's Next?June 25, 2025 | marketbeat.comLeerink Partners Slashes MannKind Corporation’s (MNKD) Price Target to $7, Keeps a Buy RatingJune 24, 2025 | insidermonkey.comMannKind Corporation (NASDAQ:MNKD) Given Average Recommendation of "Buy" by BrokeragesJune 24, 2025 | marketbeat.comMannKind FY2026 EPS Forecast Decreased by Leerink PartnrsJune 19, 2025 | marketbeat.comMannKind (NASDAQ:MNKD) Reaches New 1-Year Low - Should You Sell?June 17, 2025 | marketbeat.comMannKind’s Afrezza: A Significantly Undervalued Investment Opportunity with Promising Clinical DataJune 16, 2025 | tipranks.comMannKind (NASDAQ:MNKD) Upgraded by Wall Street Zen to "Buy" RatingJune 14, 2025 | marketbeat.comInsider Selling: MannKind Co. (NASDAQ:MNKD) Director Sells 64,085 Shares of StockJune 11, 2025 | insidertrades.comInsider Sell: Steven Binder Sells 64,085 Shares of MannKind Corp (MNKD)June 10, 2025 | gurufocus.comMannKind Co. (NASDAQ:MNKD) Director Sells 64,085 SharesJune 10, 2025 | marketbeat.comMannKind’s Strategic Growth Potential and Market Positioning: A Buy RecommendationJune 10, 2025 | tipranks.comMannKind (NASDAQ:MNKD) Sets New 1-Year Low - Time to Sell?June 10, 2025 | marketbeat.comCantor Fitzgerald Estimates MannKind FY2026 EarningsJune 10, 2025 | marketbeat.comMannKind Corp (MNKD) to Showcase Inhaled Insulin at ADA's 85th Scientific Sessions | MNKD stock newsJune 9, 2025 | gurufocus.comMannKind to present inhaled insulin study at ADA eventJune 9, 2025 | investing.comMannKind to Highlight Data from Recent Pediatric and Adult Studies of Inhaled Insulin (Afrezza®) at American Diabetes Association's 85th Scientific Sessions in Chicago, June 20-23June 9, 2025 | globenewswire.comMannKind (NASDAQ:MNKD) Stock Rating Lowered by Wall Street ZenJune 6, 2025 | marketbeat.com180 Wealth Advisors LLC Has $11.04 Million Holdings in MannKind Co. (NASDAQ:MNKD)June 2, 2025 | marketbeat.comMannKind Co. (NASDAQ:MNKD) Given Average Recommendation of "Buy" by BrokeragesMay 31, 2025 | marketbeat.comINDYCAR Driver Conor Daly To Share His Personal Diabetes Story and Race Go-Karts With Detroit Area Youth On Thursday, May 29May 27, 2025 | globenewswire.comVoloridge Investment Management LLC Has $6.86 Million Stake in MannKind Co. (NASDAQ:MNKD)May 27, 2025 | marketbeat.comNuveen Asset Management LLC Lowers Stake in MannKind Co. (NASDAQ:MNKD)May 27, 2025 | marketbeat.comTwo Sigma Advisers LP Boosts Stock Holdings in MannKind Co. (NASDAQ:MNKD)May 24, 2025 | marketbeat.comTwo Sigma Investments LP Boosts Stock Holdings in MannKind Co. (NASDAQ:MNKD)May 24, 2025 | marketbeat.comMan Group plc Purchases 219,891 Shares of MannKind Co. (NASDAQ:MNKD)May 24, 2025 | marketbeat.comMillennium Management LLC Has $22.17 Million Stake in MannKind Co. (NASDAQ:MNKD)May 23, 2025 | marketbeat.comMannKind Co. (NASDAQ:MNKD) Shares Acquired by Deutsche Bank AGMay 23, 2025 | marketbeat.comBank of America Corp DE Raises Position in MannKind Co. (NASDAQ:MNKD)May 22, 2025 | marketbeat.comInsider Selling: MannKind Co. (NASDAQ:MNKD) EVP Sells 2,345 Shares of StockMay 21, 2025 | insidertrades.comNomura Holdings Inc. Sells 2,792,237 Shares of MannKind Co. (NASDAQ:MNKD)May 21, 2025 | marketbeat.comMannKind Stockholders Approve Board and CompensationMay 19, 2025 | tipranks.comDavid Thomson Sells 32,179 Shares of MannKind Co. (NASDAQ:MNKD) StockMay 16, 2025 | insidertrades.comMannKind Co. (NASDAQ:MNKD) Stake Lowered by Parkman Healthcare Partners LLCMay 16, 2025 | marketbeat.comCantor Fitzgerald Expects Stronger Earnings for MannKindMay 16, 2025 | marketbeat.comBNP Paribas Financial Markets Boosts Stock Position in MannKind Co. (NASDAQ:MNKD)May 16, 2025 | marketbeat.comMannKind Co. (NASDAQ:MNKD) Shares Purchased by Northern Trust CorpMay 16, 2025 | marketbeat.comMannKind corp director Steven Binder sells $375,875 in stockMay 15, 2025 | investing.comMannKind EVP David Thomson sells shares worth $150,597May 15, 2025 | investing.comD. E. Shaw & Co. Inc. Has $27.45 Million Holdings in MannKind Co. (NASDAQ:MNKD)May 14, 2025 | marketbeat.comMannKind to Present at Upcoming Investor ConferencesMay 13, 2025 | globenewswire.comPromising Clinical Data and Market Potential Drive Buy Rating for MannKind’s AfrezzaMay 12, 2025 | tipranks.comGraham Capital Management L.P. Makes New Investment in MannKind Co. (NASDAQ:MNKD)May 12, 2025 | marketbeat.comMannKind Co. (NASDAQ:MNKD) Shares Sold by Tudor Investment Corp ET ALMay 11, 2025 | marketbeat.comDimensional Fund Advisors LP Acquires 855,261 Shares of MannKind Co. (NASDAQ:MNKD)May 10, 2025 | marketbeat.comMannKind Corporation (MNKD): Among the Best Cancer Stocks to Invest in for Long-Term GainMay 9, 2025 | insidermonkey.com Get MannKind News Delivered to You Automatically Sign up to receive the latest news and ratings for MNKD and its competitors with MarketBeat's FREE daily newsletter. Email Address MNKD Media Mentions By Week MNKD Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. MNKD News Sentiment▼-1.010.57▲Average Medical News Sentiment MNKD News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. MNKD Articles This Week▼25▲MNKD Articles Average Week Get MannKind News Delivered to You Automatically Sign up to receive the latest news and ratings for MNKD and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies Ligand Pharmaceuticals News BioCryst Pharmaceuticals News Amicus Therapeutics News Celldex Therapeutics News Innoviva News Dynavax Technologies News OPKO Health News Novavax News Geron News Regulus Therapeutics News Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:MNKD) was last updated on 7/8/2025 by MarketBeat.com Staff From Our PartnersEveryone’s watching Nvidia right now. Here’s why I’m excited.So, unless you’ve been living under a rock, you probably saw the news… Nvidia just signed a $7 BILLION deal...Timothy Sykes | SponsoredF1 Engineering Powers This Electric Marine MotorThe future of marine propulsion has arrived - powered by F-1 grade engineering. In collaboration with McLar...The Tomorrow Investor | SponsoredMarket Panic: Trump Just Dropped a Bomb on Your Stockstock Market Panic: Trump Just Dropped a Bomb on Your Stocks The market is in freefall—and Trump's new tarif...American Alternative | SponsoredWhite House to reset Social Security?Elon Musk's parting DOGE gift looks set to shock America... A single announcement by July 22nd could soon b...Altimetry | SponsoredThis Signal Only Flashes Once Every 4 Years – And It Just TriggeredThis same signal has appeared twice before in the past 8 years — both times, it kicked off major moves in cryp...Crypto Swap Profits | SponsoredInstant Cash (in 4 clicks)Since 1973, Wall Street has quietly used a strange little pricing quirk to cash flow billions. Now, for the...Awesomely, LLC | SponsoredINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | SponsoredTrump set to Boost Social Security Checks by 400%?If you're collecting or planning to collect social security... You should see this presentation about Presi...InvestorPlace | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding MannKind Corporation Please log in to your account or sign up in order to add this asset to your watchlist. Share MannKind With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
